WallStreetZenWallStreetZen

NASDAQ: NCEL
Newcelx Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for NCEL

Based on 1 analyst offering 12 month price targets for Newcelx Ltd

Min Forecast
$23.00+674.41%
Avg Forecast
$23.00+674.41%
Max Forecast
$23.00+674.41%

Should I buy or sell NCEL stock?

Based on 1 analyst offering ratings for Newcelx Ltd.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their NCEL stock forecasts and price targets.

NCEL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-07-13

1 of 1

Forecast return on equity

Is NCEL forecast to generate an efficient return?

Company
-67.27%
Industry
-19.77%
Market
147.72%
NCEL's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NCEL forecast to generate an efficient return on assets?

Company
-41.89%
Industry
-4.23%
NCEL is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NCEL earnings per share forecast

What is NCEL's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$1.20-116.31%
Avg 2 year Forecast
-$0.61-108.29%
Avg 3 year Forecast
-$0.75-110.23%

NCEL revenue forecast

What is NCEL's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$0.0

NCEL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NCEL$2.97$23.00+674.41%Strong Buy
GNTA$0.68N/AN/A
CTXR$0.58$4.00+593.24%Buy
ICU$3.58$8.00+123.46%Strong Buy
BCDA$1.08$25.00+2,214.81%Buy
View Top Biotech Stocks

Newcelx Stock Forecast FAQ

Is Newcelx Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: NCEL) stock is to Strong Buy NCEL stock.

Out of 1 analyst, 1 (100%) are recommending NCEL as a Strong Buy, 0 (0%) are recommending NCEL as a Buy, 0 (0%) are recommending NCEL as a Hold, 0 (0%) are recommending NCEL as a Sell, and 0 (0%) are recommending NCEL as a Strong Sell.

If you're new to stock investing, here's how to buy Newcelx stock.

What is NCEL's earnings growth forecast for 2026-2028?

(NASDAQ: NCEL) Newcelx's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.73%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 62.52%.

Newcelx's earnings in 2026 is -$9,732,123.On average, 3 Wall Street analysts forecast NCEL's earnings for 2026 to be -$6,480,027, with the lowest NCEL earnings forecast at -$6,225,908, and the highest NCEL earnings forecast at -$6,670,616. On average, 3 Wall Street analysts forecast NCEL's earnings for 2027 to be -$3,294,929, with the lowest NCEL earnings forecast at -$3,165,716, and the highest NCEL earnings forecast at -$3,391,839.

In 2028, NCEL is forecast to generate -$4,063,746 in earnings, with the lowest earnings forecast at -$3,904,383 and the highest earnings forecast at -$4,183,268.

What is NCEL's revenue growth forecast for 2026-2028?

(NASDAQ: NCEL) Newcelx's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 46.42%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.31%.

Newcelx's revenue in 2026 is $0.On average, 3 Wall Street analysts forecast NCEL's revenue for 2026 to be $0, with the lowest NCEL revenue forecast at $0, and the highest NCEL revenue forecast at $0. On average, 3 Wall Street analysts forecast NCEL's revenue for 2027 to be $0, with the lowest NCEL revenue forecast at $0, and the highest NCEL revenue forecast at $0.

In 2028, NCEL is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is NCEL's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: NCEL) forecast ROA is -41.89%, which is lower than the forecast US Biotechnology industry average of -4.23%.

What is NCEL's Price Target?

According to 1 Wall Street analyst that have issued a 1 year NCEL price target, the average NCEL price target is $23.00, with the highest NCEL stock price forecast at $23.00 and the lowest NCEL stock price forecast at $23.00.

The Wall Street analyst predicted that Newcelx's share price could reach $23.00 by Jul 13, 2027. The average Newcelx stock price prediction forecasts a potential upside of 674.41% from the current NCEL share price of $2.97.

What is NCEL's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: NCEL) Newcelx's current Earnings Per Share (EPS) is $7.38. On average, analysts forecast that NCEL's EPS will be -$1.20 for 2026, with the lowest EPS forecast at -$1.16, and the highest EPS forecast at -$1.24. On average, analysts forecast that NCEL's EPS will be -$0.61 for 2027, with the lowest EPS forecast at -$0.59, and the highest EPS forecast at -$0.63. In 2028, NCEL's EPS is forecast to hit -$0.75 (min: -$0.73, max: -$0.78).

What is NCEL's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: NCEL) forecast ROE is -67.27%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.